Sun set for generic Uroxatral ER launch in US with 180-day exclusivity
This article was originally published in Scrip
Executive Summary
Sun Pharmaceutical Industries is moving towards the launch in the US of alfuzosin hydrochloride extended release tablets, a generic version of Sanofi-Aventis' Uroxatral ER tablets.